Our Journey

A Story of Growth, Innovation, and Excellence Since 2016

Since its establishment in 2016, Al-Madar Pharma has grown into one of Yemen's leading pharmaceutical distribution and agency companies. Our journey is defined by strategic partnerships, continuous innovation, and a strong commitment to expanding access to quality healthcare nationwide.

Milestones & Achievements

2016

Foundation & Establishment

Al-Madar Pharma was established with a clear vision to elevate Yemen's pharmaceutical sector through structured planning and regulatory compliance.

Company legally established
Comprehensive national market research conducted
Strategic business and operational plans developed

2017

First Major Partnership

Entered the pharmaceutical market through the first exclusive agency agreement with SG Healthcare (India), marking the beginning of portfolio and geographic expansion.

Exclusive partnership with SG Healthcare
40+ pharmaceutical products added
Branches established in Sana'a, Ibb, Al-Hodeida, and Dhamar

2018-2019

Russian Market Expansion

Strengthened international presence through exclusive representation of Ozon LLC (Russia) and additional Russian pharmaceutical manufacturers, significantly expanding the company's registered product portfolio in Yemen.

Exclusive agency with Ozon LLC (Russia)
28 pharmaceutical products fully registered with the Authority of Medicine Registration
68 additional products received initial approval from the Authority of Medicine Registration
USD 400,000+ first-year sales performance
Partnerships with Kras pharma, Pharmacare, and Marbiopharm

2020

Digital Transformation

Invested in operational excellence through system integration and digital infrastructure.

Strategic partnership with Shamil Laboratories (India)
Deployment of ERP system (CRM, DCR, Inventory, Distribution, Fleet Tracking)
End-to-end digital process integration

2021

Brand & Portfolio Expansion

Launched the In-Milk infant formula brand, developed with premium ingredients sourced from New Zealand, and expanded the company's portfolio through exclusive pharmaceutical representation.

In-Milk infant formula brand successfully launched
Premium New Zealand–sourced ingredients
Exclusive agency secured with Yoo Young Pharmaceuticals (South Korea)

2022-2023

Medical Devices Expansion

Expanded into the medical devices sector through a strategic partnership with OPTLINE, while further strengthening the pharmaceutical portfolio through exclusive agency representation.

OPTLINE medical devices partnership
Exclusive agency secured with UBM Pharmaceutical Industries
Expansion of branch and distribution network

2024-2025

Strategic Diversification

Continued growth through expansion into high-potential healthcare segments, including vitamins, nutritional supplements, cosmetics, personal care, and private-label healthcare products, strengthening the company's diversified portfolio.

Vitamins and nutritional supplements expansion
Cosmetics and personal care portfolio development
Private-label healthcare product development

Our Achievements at a Glance

Years of Excellence

15+

Global Partners

Branches Nationwide

120+

Products

400+

Team Members

150+

Delivery Vehicles